Authors
Latest:
Fighting the Flu With Supplements: The Pharmacist’s Patient Counseling GuideConfusing product labeling and conflicting data can create challenges for patients.
Latest:
Early Experience Using Intravesical Gene Therapy for NMIBC: Perspectives from Urinary OncologistsFor more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.
Latest:
Removal of Phenylephrine From Nasal Decongestants Could Reshape OTC Cold RemediesIntranasal decongestants are preferred alternatives to oral phenylephrine for relief of nasal congestion.
Latest:
A Dab of MAB: Lecanemab, Aducanumab vs Standard of Care Treatment for Alzheimer DiseasePharmacists play a key role in the management of modern monoclonal antibody treatments for Alzheimer disease.
Latest:
Precision Bayesian Modeling Tailors Vancomycin Dosing in Patients With ObesityThe future of vancomycin dosing lies in optimizing dosing regimens to individual patient needs.
Latest:
Clinical Insight: The Use of GLP-1 Agonist Medications for Weight LossAn increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.
Latest:
Empower Prospective Pharmacists through Children’s BooksThis short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.
Latest:
Pharma Can Help Transform Patient Centricity in 2024True patient centricity treats the whole patient and places an emphasis on broader patient engagement and satisfaction.
Latest:
Addressing Mental Health Disparities in Black WomenPharmacists are accessible and trusted health care professionals who have an important role in supporting people living with mental illness.
Latest:
Novel Immunotherapies in Perioperative Setting in Muscle-Invasive Bladder Cancer May Transform Clinical PracticeSystemic treatment options have historically been limited to traditional chemotherapy agents.
Latest:
Clinical Overview: Cyletzo, a Biosimilar Version of AdalimumabIndications for adalimumab include ankylosing spondylitis, Crohn disease, chronic plaque psoriasis, juvenile idiopathic arthritis, moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
Latest:
Early Experience Using Intravesical Gene Therapy for NMIBC: Perspectives from Urinary OncologistsFor more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.
Latest:
Behind the Counter Codeine Preparations Require Diligent CareIt is the role of the pharmacist to ensure patients are adequately counseled on the adverse effects and potential harms of codeine.
Latest:
Developing and Implementing Immunization Standing Orders and ProtocolsVaccine administration provides benefits at the patient and public health levels, and pharmacists are critical members of health care teams that provide these vital biologic medications.
Latest:
The Role of Tirofiban for Acute Coronary Syndrome Remains UnclearThe RESCUE BT2 trial sheds further light on the agent’s potential.
Latest:
Pharmacy Colorectal Cancer Screening Protocol Shows Potential of Pharmacists in Preventative HealthThe opportunity to provide non-invasive colorectal cancer screening and education to patients is undoubtedly a role that pharmacists can fill.
Latest:
New Evidence in Recurrent Acute Tonsillitis in Adults Shows Benefit of Tonsillectomy Over AntibioticsThroat indications contribute to high antibiotic overprescribing rates.
Latest:
Common Medication Errors in LTC Communities: What Pharmacists Can Do To Help Prevent ThemThe most common medication errors seen in LTC facilities include dispensing errors, delay in delivery, and expired inventory.
Latest:
Pharmacy Measures and Policy Considerations for Pharmacy PracticeThere are several important policy issues that could impact pharmacists’ ability to positively affect the quality of care for patients through the use of pharmacy performance measures.
Latest:
Antineoplastic Extravasation Prevention, ManagementExtravasation is defined as the inadvertent leakage of a vesicant from the vein into the surrounding tissue.
Latest:
A Pharmacist’s Guide to Continuous Glucose MonitoringThis guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.
Latest:
Clinical Overview: Fecal Microbiota Transplantation vs Live Biotherapeutic Products for Management of Recurrent C Difficile InfectionAlthough antibiotics are the standard-of-care treatment for Clostridioides difficile infection, they can cause further microbiota changes that predispose patients to recurrence.
Latest:
Understanding Pharmacogenomics Is Essential for Personalized CarePharmacogenomics can play a role in lowering the cost of health care expenditures, such as shortening hospital stays and reducing emergency department visits.
Latest:
Case Study: Treating Chronic Hypertension in PregnancyChronic hypertension during pregnancy increases the risk of poor pregnancy and birth outcomes.
Latest:
Guidelines for Medication Disposal: Take Back DayThose looking to dispense medications should consult the individual guidelines for their local Take Back Bin.
Latest:
HSSP Leads to High Rate of Acid Suppression Therapy SubstitutionThis study highlights one benefit of the integrated health system specialty pharmacy model for patients who are prescribed acalabrutinib.
Latest:
Positioning Specialty Pharmacy to Care for Solid Organ Transplant RecipientsA specialty pharmacy can effectively dispense, monitor, and follow-up with transplant patients who are maintained on the standard triple-drug immunosuppression regimen.
Latest:
Sortilin Targeted Peptide-Drug Conjugates: A New Mechanism to Extend Clinical BenefitData suggest the therapy can induce prolonged clinical benefit, even after treatment discontinuation.
